Identifying modifiable and non-modifiable risk factors of epithelial ovarian cancer—can we get it better?

Ovarian cancer is the fifth most common cancer in women worldwide, with an estimated lifetime risk of one in 54–75, and one in 100 of ovarian cancer-related mortality (1). The role of irreversible and reversible risk factors in development of epithelial ovarian cancer (EOC) has been researched extensively, with a heavy focus on genetic factors and family history of breast/ovarian cancer.